Les publications majeures

sur la toxicité de l’aluminium vaccinal

Pr Exley - L‘ère de l’aluminium

Aujourd’hui, nous avons tous de l’aluminium dans notre corps et il est probable qu’il soit présent dans chaque compartiment physique et chimique du corps humain.

A un moment donné, sa toxicité se déploiera, les systèmes cérébraux deviendront dysfonctionnels et des cascades d’événements, aboutissant éventuellement à une perte accélérée de cellules et de neurones, commenceront à dominer.

Lire la publication

Pr Yehuda Shoenfeld - Le syndrome des adjuvants

Les affections du système immunitaire sont une cause majeure de maladie et de mortalité à travers le monde, et leur nombre est en augmentation.

On a découvert que des adjuvants (dont l’aluminium) induisaient par eux-mêmes une réaction auto-immune chez différents modèles animaux et pouvaient peut-être provoquer une maladie auto-immune ou auto-inflammatoire chez l’homme.

Lire la publication

Pr Gherardi - La migration de l‘aluminium dans l’organisme

La biodistribution de l’hydroxyde d’aluminium est largement inconnue. Des expériences sur des souris ont été menées pour l’évaluer.

L’injection intramusculaire d’un vaccin contenant de l’aluminium est associée à l’apparition de dépôts d’aluminium dans des organes éloignés tels que la rate et le cerveau où ils étaient encore détectés un an après l’injection.

Lire la publication

Pr Authier - La myofasciite à macrophages

La myofasciite à macrophages se caractérise par des lésions musculaires attestant d’une persistance anormale de sels d’aluminium dans les macrophages.

La plupart des sujets souffrent d’arthromyalgie, de fatigue chronique et de troubles cognitifs à l’origine d’une exclusion sociale.

Lire la publication

Dr Sing Hang Lee - Gardasil : attention, danger

Des échantillons de Gardasil ont été testés. Toutes les ampoules de Gardasil contenaient des fragments d’ADN, probablement liés à des nanoparticules de sulfate d’hydroxyphosphate d’aluminium.

La sécurité vaccinale nécessite qu’une investigation approfondie soit menée.

Lire la publication

Pr Gherardi - État des connaissances

Cette publication fait le point des connaissances sur la biopersistance inattendue de l’aluminium au site d’injection vaccinal, et sur le processus de migration de cet aluminium dans l’organisme.

Elle liste aussi les questions majeures en suspens, qui nécessitent des réponses urgentes.

Lire la publication

Liste des principales publications

– Liste non exhaustive –

2019

2019.05 – Myalgia and chronic fatigue syndrome following immunization : macrophagic myofasciitis and animal studies support linkage to aluminum adjuvant persistency and diffusion in the immune system – Romain K. Gherardia, Guillemette Crépeaux, François-Jérome Authier

2019.08 – Aluminium in human brain tissue: how much is too much? – Christopher Exley · Matthew J. Mold

De 2015 à 2018

2018.10 – Cognition and behavior in sheep repetitively inoculated with aluminum adjuvant-containing vaccines or aluminum adjuvant only – Javier Asin, Maria Pascual-Alonso, Pedro Pinczowski, Marina Gimeno, Marta Perez, Ana Muniesa, Lorena de Pablo, Ignacio de Blas, Delia Lacasta, Antonio Fernandez, Damian de Andres, Gustavo Marıa, Ramses Reina, Lluıs Lujan

2018.10 – Granulomas Following Subcutaneous Injection With Aluminum Adjuvant-Containing Products in Sheep – Javier Asın, Jessica Molın, Marta Perez, Pedro Pinczowski, Marina Gimeno, Nuria Navascues, Ana Muniesa, Ignacio de Blas, Delia Lacasta, Antonio Fernandez, Lorena de Pablo, Matthew Mold , Christopher Exley, Damian de Andres, Ramses Reina, and Lluıs Lujan

2018.10 – Molecular Signature of Aluminum Hydroxide Adjuvant in Ovine PBMCs by Integrated mRNA and microRNA Transcriptome Sequencing – Endika Varela-Martínez, Naiara Abendaño, Javier Asín, Maialen Sistiaga-Poveda, Marta Maria Pérez, Ramsés Reina, Damián de Andrés, Lluís Luján and Begoña M. Jugo

2018.08 – Aluminium in Brain Tissue in Multiple Sclerosis – M. Mold, A. Chmielecka, M. R. Ramirez Rodriguez, F. Thom, C. Linhart, A. King, C. Exley

2017.12 – Aluminium in brain tissue in autisme – M. Mold, D. Umar, A. King, C. Exley

2017.07 – Adjuvants aluminiques des vaccins : analyse critique des études toxicocinétiques de référence

2017.01 Non-linear dose-response of aluminium hydroxide adjuvant particles: Selective low dose neurotoxicity – Crépeaux G & al. in Toxicology

2016.11 – Murine hypothalamic destruction with vascular cell apoptosis subsequent to combined administration of human papilloma virus vaccine and pertussis toxin – Aratani S & al. in Nature – Scientific reports

2016.10 – Brain FDG-PET metabolic abnormalities in patients with long-lasting macrophagic myofasciitis – Van Der Gucht A & al. in J Nucl Med

2016.10 – Calcium phosphate: a substitute for aluminum adjuvants? – Masson JD & al. in Expert Rev Vaccines

2016.08 – Insight into the cellular fate and toxicity of aluminium adjuvants used in clinically approved human vaccinations – Mold M & al. in Nature – Scientific reports

2016.07 – Behavioral abnormalities in female mice following administration of aluminum adjuvants and the human papillomavirus (HPV) vaccine Gardasil – Inbar R & al. in Immunol Res.

2016.06 – Sujet périphérique (aluminium et antiperspirant) – Aluminium and the human breast – Darbre PD in Morphologie.

2016.06 – Aluminum adjuvants of vaccines injected into the muscle: Normal fate, pathology and associated disease – Gherardi RK & al. in Morphologie

2015.11 – Highly delayed systemic translocation of aluminum-based adjuvant in CD1 mice following intramuscular injections – Crépeaux G & al. in J Inorg Biochem

2015.11 – Aluminum induces inflammatory and proteolytic alterations in human monocytic cell line – Ligi D & al. in J Inorg Biochem

2015.10 – Vaccines, adjuvants and autoimmunity – Guimarães LE & al. in Pharmacol Res

2015.08 – A link between human papilloma virus vaccination and primary ovarian insufficiency: current analysis – Gruber N & al. in Curr Opin Obstet Gynecol

2015.07 – Highly delayed systemic translocation of aluminum-based adjuvant in CD1 mice following intramuscular injections. –Crépeaux G, Eidi H, David MO, Tzavara E, Giros B, Exley C, Curmi PA, Shaw CA, Gherardi RK, Cadusseau J – J Inorg Biochem.

2015.06 – Neuropsychological Correlates of Brain Perfusion SPECT in Patients with Macrophagic Myofasciitis – Axel Van Der Gucht, Mehdi Aoun Sebaiti, Emmanuel Itti, Jessie Aouizerate, Eva Evangelista, Julia Chalaye, Romain K. Gherardi, Nilusha Ragunathan-Thangarajah, Anne-Catherine Bachoud-Levi, François-Jérôme Authier.

2015.05 – Fluorescent nanodiamonds as a relevant tag for the assessment of alum adjuvant particle biodisposition – Eidi H & al. in BMC Med.2015.11 – Aluminum induces inflammatory and proteolytic alterations in human monocytic cell line – Ligi D & al. in J Inorg Biochem

2015.01 – Exposure to mercury and aluminum in early life: developmental vulnerability as a modifying factor in neurologic and – immunologic effects. – Dórea JG. Int J Environ Res Public Health.

2015 – Biopersistence and brain translocation of aluminum adjuvants of vaccines – Romain Kroum Gherardi, Housam Eidi, Guillemette Crépeaux, François Jerome Authier and Josette Cadusseau – Frontiers in Neurology doi: 10.3389/fneur.2015.00004.

De 2011 à 2014

2014 – Selective elevation of circulating CCL2/MCP1 levels in patients with longstanding post-vaccinal macrophagic myofasciitis and ASIA – Josette Cadusseau, Nilusha Ragunathan-Thangarajah, Mathieu Surenaud, Sophie Hue, François-Jérôme Authier, et Romain K. Gherardi.

2014 – Macrophagic myofasciitis and vaccination: Consequence or coincidence? – T. Santiago · O. Rebelo · L. Negrão · A. Matos – Rheumatol Int – DOI 10.1007/s00296-014-3065-4.

2014 – Etiology of autism spectrum disorders: Genes, environment, or both ? – C. A. Shaw, S. Sheth, D. Li, L. Tomljenovic – OA Autism 2014 Jun 10;2(2):11.

2014 – Why industry propaganda and political interference cannot disguise the inevitable role played by human exposure to aluminum in neurodegenerative diseases, including Alzheimer’s disease – Christopher Exley – Front. Neurol. 5:212. doi: 10.3389/fneur.2014.00212.

2014 – Aluminum-Induced Entropy in Biological Systems: Implications for Neurological Disease – Christopher A. Shaw, Stephanie Seneff, Stephen D. Kette, Lucija Tomljenovic, JohnW. Oller Jr., and RobertM. Davidson.

2014 – Are there negative CNS impacts of aluminum adjuvants used in vaccines and immunotherapy? – Christopher A Shaw, Dan Li & Lucija Tomljenovic- Immunotherapy 2014;6(10):1055-71. doi: 10.2217/imt.14.81.

2014 – Evolution of multiple sclerosis in France since the beginning of hepatitis B vaccination – Dominique Le Houezec – Immunol Res DOI 10.1007/s12026-014-8574-4.

2014 – Clinical features in patients with long-lasting macrophagic myofasciitis – Muriel Rigolet, Jessie Aouizerate, Maryline Couette, Nilusha Ragunathan-Thangarajah, Mehdi Aoun-Sebaiti, Romain Kroum Gherardi, Josette Cadusseau and François Jérôme Authier  – Frontiers in Neurology PMID: 25506338.

2014 – Aluminum and Glyphosate Can Synergistically Induce Pineal Gland Pathology: Connection to Gut Dysbiosis and Neurological Disease – Stephanie Seneff, Nancy Swanson, Chen Li – Agricultural Sciences, 2015, 6, 42-70.

2013 – Slow CCL2-dependent translocation of biopersistent particles from muscle to brain (Khan Z, Combadière C, Authier FJ, Itier V, Lux F, Exley C, Mahrouf-Yorgov M, Decrouy X, Moretto P, Tillement O, Gherardi RK, Cadusseau J.- France – BMC Med).

2013 – Autoimmune/autoinflammatory syndrome induced by adjuvants (ASIA syndrome) in commercial sheep (Lluís Luján, Marta Pérez, Eider Salazar, Neila Álvarez, Marina Gimeno, Pedro Pinczowski, Silvia Irusta, Jesús Santamaría, et al – Espagne – Immunologic Research).

2013 – Aluminum in the central nervous system (CNS): toxicity in humans and animals, vaccine adjuvants, and autoimmunity (Shaw CA, Tomljenovic L – Canada – Immunol Res).

2013 – Administration of aluminium to neonatal mice in vaccine-relevant amounts is associated with adverse long term neurological outcomes (Shaw CA, Li Y, Tomljenovic L – Canada – Journal of Inorganic Biochemistry).

2013 – Distinctive clinical features in arthro-myalgic patients with and without aluminum hydroxyde-induced macrophagic myofasciitis: An exploratory study (Nilusha Ragunathan-Thangarajah, Christine Le Beller, Pierre Boutouyrie, Guillaume Bassez, Romain K. Gherardi, Stéphane Laurent, François-Jérôme Authier – France – Journal of Inorganic Biochemistry).

2013 – Aluminum enhances inflammation and decreases mucosal healing in experimental colitis in mice – G Pineton de Chambrun,MBody-Malapel, I Frey-Wagner, MDjouina, F Deknuydt, K Atrott, N Esquerre3, F Altare, C Neut, MC Arrieta, T-D Kanneganti, G Rogler, J-F Colombel, A Cortot, P Desreumaux and C Vignal – MucosalImmunology – published online 16 October 2013. doi:10.1038/mi.2013.78 – PMID : 24129165.

2013 – Aluminum’s Role in CNS-immune System Interactions leading to Neurological Disorders – Shaw CA, Kette SD, Davidson RM and Seneff S – Immunome Res 9: 069. doi: 10.4172/1745-7580.1000069.

2013 – Autoimmune/inflammatory syndrome induced by adjuvants (ASIA) 2013: Unveiling the pathogenic, clinical and diagnostic aspects – Carlo Perricone, Serena Colafrancesco, Roei D. Mazor, Alessandra Soriano, Nancy Agmon-Levin, Yehuda Shoenfeld – Journal of Autoimmunity (2013), http://dx.doi.org/10.1016/j.jaut.2013.10.004.

2012 – Macrophagic myofasciitis: characterization and pathophysiology (RK Gherardi and FJ Authier – France – Lupus). Traduction française E3M.

2012 – Mechanisms of aluminum adjuvant toxicity and autoimmunity in pediatric populations (Tomljenovic L, Shaw CA – Canada – Lupus).

2012 – Hepatitis B vaccine induces apoptotic death in Hepa1–6 cells (Heyam Hamza, Jianhua Cao, Xinyun Li, Changchun Li, Mengjin Zhu, Shuhong Zhao – Chine – Apoptosis).

2012 – Empirical Data Confirm Autism Symptoms Related to Aluminum and Acetaminophen Exposure (Stephanie Seneff, Robert M. Davidson,  and Jingjing Liu – USA – Entropy).

2011 – Aluminum Vaccine Adjuvants: Are they Safe? (L. Tomljenovic et C.A. Shaw – Canada – Current Medicinal Chemistry). Traduction française E3M.

2011 – Do aluminum vaccine adjuvants contribute to the rising prevalence of autism? – L. Tomljenovic, C. Shaw – Journal of Inorganic Biochemistry.

De 1998 à 2010

2010 – The immunobiology of aluminium adjuvants: how do they really work? (C. Exley, P. Siesjo et H. Eriksson – Grande-Bretagne – Trends in Immunology). Traduction française E3M.

2010 – Infants’ exposure to aluminum from vaccines and breast milk during the first 6 months (J.Dórea JG, Marques RC.- Brésil – Expo Sci Environ Epidemiol).

2010 – « ASIA » – Syndrome auto-immunitaire/inflammatoire induit par les adjuvants (Y. Shoenfeld et N. Agmon-Levin – Israël – Journal of Autoimmunity). Traduction française E3M.

2009 – Long-term persistence of vaccine-derived aluminum hydroxide is associated with chronic cognitive dysfunction (M. Couette, M.F. Boisse, P. Maison, P. Brugieres, P. Cesaro, X. Chevalier, R. K. Gherardi, A-C. Bachoud-Levi et F-J. Authier – France – Journal of Inorganic Biochemistry). Traduction française E3M.

2009 – Aluminum hydroxide injections lead to motor deficits and motor neuron degeneration (C. A. Shaw et M.S. Petrik – Canada – Journal of Inorganic Biochemistry). Traduction française E3M.

2008 – A role for the body burden of aluminium in vaccine-associated macrophagic myofasciitis and chronic fatigue syndrome (C. Exley, L. Swarbrick, R. K. Gherardi et F-J. Authier – Grande-Bretagne, France – Elsevier, Medical Hypotheses). Traduction française E3M.

2001 – Macrophagic myofasciitis lesions assess long-term persistence of vaccine-derived aluminium hydroxide in muscle (R. K. Gherardi, M. Coquet, P. Chérin, L. Belec, P. Moretto, P-A. Dreyfus, J-F. Pellissier, P. Chariot et F-J. Authier – Brain). Traduction française E3M.

1998 – Macrophagic myofasciitis: an emerging entity (Gherardi RK, Coquet M, Chérin P, Authier FJ, Laforêt P, Bélec L, Figarella-Branger D, Mussini JM, Pellissier JF, Fardeau M. – Lancet).